Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04270474 · ClinicalTrials.gov registry record · NA

Reducing Risk of Dementia Through Deprescribing

A NA study of Dementia and Alzheimer Disease, Late Onset, sponsored by Indiana University.

Active
Registry status
NA
Development phase
344
Enrollment target
2
Study locations

NCT04270474 is a NA study of Dementia and Alzheimer Disease, Late Onset that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 344 participants, below the 7,721-participant average among 199 other Dementia trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04270474, a NA study of Dementia and Alzheimer Disease, Late Onset, is active but no longer recruiting, sponsored by Indiana University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
344 participants
Enrollment target
2
Study locations

Study Summary

A cluster-randomized controlled trial (RCT) called "Reducing Risk of Dementia through Deprescribing" (R2D2) to evaluate the impact of a deprescribing intervention on important cognitive and safety outcomes.

Conditions Studied

Dementia Alzheimer Disease, Late Onset

Interventions

  • OTHER Usual Care
  • OTHER Deprescribing of target anticholinergics

Study Locations (2)

Indiana

  • Indiana University Health - Indianapolis
  • Community Health Network Foundation, Inc. - Indianapolis

Trial Details

FieldValue
Enrollment Target 344 participants
Start Date 2020-07-20
Est. Completion 2026-07-30
Phase NA

Sponsor

Indiana University

890 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04270474

The ClinicalTrials.gov registry entry for NCT04270474 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 344 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,721-participant average among 199 other Dementia trials with a reported enrollment target (96% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT04270474 reports 2 study locations spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT04270474 about?

NCT04270474 is a clinical study titled "Reducing Risk of Dementia Through Deprescribing". A cluster-randomized controlled trial (RCT) called "Reducing Risk of Dementia through Deprescribing" (R2D2) to evaluate the impact of a deprescribing intervention on important cognitive and safety outcomes.

What is the current status of trial NCT04270474?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 344 participants. The study started on 2020-07-20. Estimated completion is 2026-07-30.

What conditions does trial NCT04270474 study?

This clinical trial studies the following conditions: Dementia, Alzheimer Disease, Late Onset.

What interventions are being tested in trial NCT04270474?

The interventions under investigation include: Usual Care (OTHER), Deprescribing of target anticholinergics (OTHER).

Who is sponsoring clinical trial NCT04270474?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04270474 being conducted?

This trial has 2 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dementia

All registered trials for this condition

Alzheimer Disease, Late Onset

All registered trials for this condition

Indiana

All trials with a study site in Indiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.